JP2022523726A5 - - Google Patents
Info
- Publication number
- JP2022523726A5 JP2022523726A5 JP2021544518A JP2021544518A JP2022523726A5 JP 2022523726 A5 JP2022523726 A5 JP 2022523726A5 JP 2021544518 A JP2021544518 A JP 2021544518A JP 2021544518 A JP2021544518 A JP 2021544518A JP 2022523726 A5 JP2022523726 A5 JP 2022523726A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- compound
- pharmaceutically acceptable
- hiv infection
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962799800P | 2019-02-01 | 2019-02-01 | |
| US62/799,800 | 2019-02-01 | ||
| PCT/IB2020/050743 WO2020157692A1 (en) | 2019-02-01 | 2020-01-30 | Inhibitors of human immunodeficiency virus replication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523726A JP2022523726A (ja) | 2022-04-26 |
| JP2022523726A5 true JP2022523726A5 (enExample) | 2023-01-26 |
Family
ID=69528890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544518A Ceased JP2022523726A (ja) | 2019-02-01 | 2020-01-30 | ヒト免疫不全ウイルス複製の阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220105096A1 (enExample) |
| EP (1) | EP3917930B1 (enExample) |
| JP (1) | JP2022523726A (enExample) |
| AR (1) | AR117920A1 (enExample) |
| ES (1) | ES2941240T3 (enExample) |
| PT (1) | PT3917930T (enExample) |
| TW (1) | TW202045502A (enExample) |
| UY (1) | UY38559A (enExample) |
| WO (1) | WO2020157692A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA53973A (fr) | 2018-10-24 | 2022-02-09 | Viiv Healthcare Uk No 5 Ltd | Inhibiteurs de la réplication du virus de l'immunodéficience humaine |
| EP3986561B1 (en) * | 2019-06-19 | 2024-02-14 | VIIV Healthcare UK (No.5) Limited | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication |
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| US12564595B2 (en) | 2019-11-28 | 2026-03-03 | Shionogi & Co., Ltd. | Prophylactic and therapeutic pharmaceutical agent for HIV infectious diseases characterized by comprising combination of integrase inhibitor and anti-HIV agent |
| IL293566A (en) * | 2019-12-09 | 2022-08-01 | Viiv Healthcare Co | Pharmaceutical preparations containing Cabotgravir |
| WO2021176366A1 (en) * | 2020-03-06 | 2021-09-10 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| US12703699B2 (en) | 2020-03-06 | 2026-08-11 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
| EP4135702B1 (en) * | 2020-04-15 | 2026-06-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| TW202448483A (zh) | 2023-05-31 | 2024-12-16 | 美商基利科學股份有限公司 | 用於ｈｉｖ之治療性化合物 |
| AR132951A1 (es) | 2023-06-15 | 2025-08-13 | Viiv Healthcare Uk No 5 Ltd | Métodos e intermedios para preparar compuestos |
| WO2025169059A1 (en) | 2024-02-05 | 2025-08-14 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| CA2840095A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| US9220710B2 (en) | 2013-01-09 | 2015-12-29 | Gilead Sciences, Inc. | Therapeutic compounds |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| EP2943493B1 (en) | 2013-01-09 | 2017-08-02 | Gilead Sciences, Inc. | Therapeutic compounds for the treatment of viral infections |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| US10035760B2 (en) | 2013-10-24 | 2018-07-31 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| US9873680B2 (en) | 2014-08-29 | 2018-01-23 | Gilead Sciences, Inc. | Therapeutic compounds |
| US9855230B2 (en) | 2014-09-09 | 2018-01-02 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| PT3286166T (pt) | 2015-04-23 | 2020-08-18 | Viiv Healthcare Uk No 5 Ltd | Inibidores de replicação do vírus da imunodeficiência humana |
| AU2016250662A1 (en) | 2015-04-23 | 2017-11-16 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| LT3347352T (lt) | 2016-08-19 | 2019-08-12 | Gilead Sciences, Inc. | Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui |
| TW201906834A (zh) | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| TW202024061A (zh) | 2017-08-17 | 2020-07-01 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| AR112412A1 (es) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
| WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
| KR102847339B1 (ko) | 2018-02-16 | 2025-08-19 | 길리애드 사이언시즈, 인코포레이티드 | 레트로비리다에 바이러스 감염의 치료에 유용한 치료 화합물을 제조하기 위한 방법 및 중간체 |
| WO2019198024A1 (en) | 2018-04-11 | 2019-10-17 | VIIV Healthcare UK (No.5) Limited | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication |
-
2020
- 2020-01-29 UY UY0001038559A patent/UY38559A/es not_active Application Discontinuation
- 2020-01-30 JP JP2021544518A patent/JP2022523726A/ja not_active Ceased
- 2020-01-30 AR ARP200100242A patent/AR117920A1/es not_active Application Discontinuation
- 2020-01-30 EP EP20704596.4A patent/EP3917930B1/en active Active
- 2020-01-30 TW TW109102689A patent/TW202045502A/zh unknown
- 2020-01-30 US US17/425,796 patent/US20220105096A1/en not_active Abandoned
- 2020-01-30 PT PT207045964T patent/PT3917930T/pt unknown
- 2020-01-30 WO PCT/IB2020/050743 patent/WO2020157692A1/en not_active Ceased
- 2020-01-30 ES ES20704596T patent/ES2941240T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK168514B1 (da) | Synergistisk produkt indeholdende en kombination af amantadin og selegilin, fremgangsmåde til fremstilling af produktet og anvendelse af amantadin og selegilin til fremstilling af produktet | |
| JP2022537047A5 (enExample) | ||
| JP2022531251A5 (enExample) | ||
| JP2023535744A5 (enExample) | ||
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP5514123B2 (ja) | 卵巣癌を治療するための、パクリタキセルを含む配合剤 | |
| KR20240032789A (ko) | 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물 | |
| JP2023537921A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| NZ541187A (en) | Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) with an inhibitor of cytochrome P450, such as protease inhibitors | |
| JP2016505561A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2023531930A5 (enExample) | ||
| JP2022553888A5 (enExample) | ||
| EP3833378B1 (en) | Treatment of warts | |
| JP2022550828A5 (enExample) | ||
| UA123780C2 (uk) | Лікування екземи кистей | |
| US20040122068A1 (en) | Pramipexole for the treatment of HIV dementia | |
| IL319451A (en) | HIV treatment with CABOTEGRAVIR and RILPIVIRINE in pediatric patients | |
| ZA200401412B (en) | Use of atazanavir in HIV therapy. | |
| CA2368352A1 (en) | Method for treating neurodegeneration | |
| CN110279691A (zh) | 一种外科术后护理镇痛药物及其用途 | |
| Shahani et al. | Status of chloroquine and hydroxychloroquine in COVID-19 infection | |
| CN104117065B (zh) | 一种基于青藤碱的用于镇痛的药物组合产品 | |
| JP2024518455A5 (enExample) |